Dong-A St - Asset Resilience Ratio

Latest as of September 2025: 9.52%

Dong-A St (170900) has an Asset Resilience Ratio of 9.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 170900 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩135.55 Billion
≈ $91.86 Million USD Cash + Short-term Investments

Total Assets

₩1.42 Trillion
≈ $964.78 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Dong-A St's Asset Resilience Ratio has changed over time. See Dong-A St shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Dong-A St's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 170900 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩135.55 Billion 9.52%
Total Liquid Assets ₩135.55 Billion 9.52%

Asset Resilience Insights

  • Limited Liquidity: Dong-A St maintains only 9.52% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Dong-A St Industry Peers by Asset Resilience Ratio

Compare Dong-A St's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Dong-A St (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Dong-A St.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 8.41% ₩117.02 Billion
≈ $79.31 Million
₩1.39 Trillion
≈ $943.16 Million
+2.58pp
2023-12-31 5.83% ₩73.67 Billion
≈ $49.93 Million
₩1.26 Trillion
≈ $856.88 Million
+3.69pp
2022-12-31 2.14% ₩24.75 Billion
≈ $16.77 Million
₩1.16 Trillion
≈ $784.57 Million
-7.71pp
2021-12-31 9.85% ₩109.89 Billion
≈ $74.47 Million
₩1.12 Trillion
≈ $756.29 Million
-1.20pp
2020-12-31 11.05% ₩108.34 Billion
≈ $73.42 Million
₩980.67 Billion
≈ $664.58 Million
+9.83pp
2019-12-31 1.22% ₩12.28 Billion
≈ $8.32 Million
₩1.01 Trillion
≈ $683.63 Million
+1.14pp
2018-12-31 0.07% ₩705.99 Million
≈ $478.44K
₩948.67 Billion
≈ $642.90 Million
-0.18pp
2017-12-31 0.25% ₩2.29 Billion
≈ $1.55 Million
₩899.72 Billion
≈ $609.73 Million
+0.14pp
2016-12-31 0.11% ₩1.18 Billion
≈ $796.28K
₩1.07 Trillion
≈ $722.83 Million
-0.10pp
2015-12-31 0.21% ₩2.20 Billion
≈ $1.49 Million
₩1.06 Trillion
≈ $720.75 Million
-1.77pp
2014-12-31 1.98% ₩21.39 Billion
≈ $14.50 Million
₩1.08 Trillion
≈ $733.16 Million
+0.63pp
2013-12-31 1.34% ₩12.51 Billion
≈ $8.48 Million
₩931.72 Billion
≈ $631.41 Million
--
pp = percentage points

About Dong-A St

KO:170900 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$275.09 Million
₩405.93 Billion KRW
Market Cap Rank
#15332 Global
#573 in Korea
Share Price
₩44300.00
Change (1 day)
-1.12%
52-Week Range
₩42450.00 - ₩57800.00
All Time High
₩155894.20
About

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bl… Read more